The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Insomnia Medication-Global Market Insights and Sales Trends 2024

Insomnia Medication-Global Market Insights and Sales Trends 2024

Publishing Date : Nov, 2023

License Type :
 

Report Code : 1830586

No of Pages : 116

Ask Your Query
Synopsis
The global Insomnia Medication market size is expected to reach US$ 3710.3 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Insomnia Medication in various end use industries. The expanding demands from the Adults and Kids, are propelling Insomnia Medication market. Nonbenzodiazepine Receptor Agonists, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Benzodiazepine Receptor Agonists segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Insomnia Medication, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Insomnia Medication market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Insomnia Medication market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Insomnia Medication sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Insomnia Medication covered in this report include Eisai, Merck, Pfizer, Sanofi, Takeda, Vanda Pharmaceuticals, Astellas, Dainippon Sumitomo and ECR Pharmaceuticals (Valeant), etc.
The global Insomnia Medication market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Eisai
Merck
Pfizer
Sanofi
Takeda
Vanda Pharmaceuticals
Astellas
Dainippon Sumitomo
ECR Pharmaceuticals (Valeant)
Flynn Pharma
Johnson & Johnson
Meda
Somnus Therapeutics
Purdue Pharma
Neurim
Minerva Neurosciences
Pernix Therapeutics
SkyePharma
Paratek Pharmaceuticals
Global Insomnia Medication market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Insomnia Medication market, Segment by Type:
Nonbenzodiazepine Receptor Agonists
Benzodiazepine Receptor Agonists
The Selective Melatonin Receptor Agonist Ramelteon
Sedating Antidepressants
Global Insomnia Medication market, by Application
Adults
Kids
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Insomnia Medication manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Insomnia Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Insomnia Medication Market Overview
1.1 Insomnia Medication Product Overview
1.2 Insomnia Medication Market Segment by Type
1.2.1 Nonbenzodiazepine Receptor Agonists
1.2.2 Benzodiazepine Receptor Agonists
1.2.3 The Selective Melatonin Receptor Agonist Ramelteon
1.2.4 Sedating Antidepressants
1.3 Global Insomnia Medication Market Size by Type
1.3.1 Global Insomnia Medication Market Size Overview by Type (2018-2029)
1.3.2 Global Insomnia Medication Historic Market Size Review by Type (2018-2023)
1.3.3 Global Insomnia Medication Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Insomnia Medication Sales Breakdown by Type (2018-2023)
1.4.2 Europe Insomnia Medication Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Insomnia Medication Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Insomnia Medication Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Insomnia Medication Sales Breakdown by Type (2018-2023)
2 Global Insomnia Medication Market Competition by Company
2.1 Global Top Players by Insomnia Medication Sales (2018-2023)
2.2 Global Top Players by Insomnia Medication Revenue (2018-2023)
2.3 Global Top Players by Insomnia Medication Price (2018-2023)
2.4 Global Top Manufacturers Insomnia Medication Manufacturing Base Distribution, Sales Area, Product Type
2.5 Insomnia Medication Market Competitive Situation and Trends
2.5.1 Insomnia Medication Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Insomnia Medication Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Insomnia Medication as of 2022)
2.7 Date of Key Manufacturers Enter into Insomnia Medication Market
2.8 Key Manufacturers Insomnia Medication Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Insomnia Medication Status and Outlook by Region
3.1 Global Insomnia Medication Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Insomnia Medication Historic Market Size by Region
3.2.1 Global Insomnia Medication Sales in Volume by Region (2018-2023)
3.2.2 Global Insomnia Medication Sales in Value by Region (2018-2023)
3.2.3 Global Insomnia Medication Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Insomnia Medication Forecasted Market Size by Region
3.3.1 Global Insomnia Medication Sales in Volume by Region (2024-2029)
3.3.2 Global Insomnia Medication Sales in Value by Region (2024-2029)
3.3.3 Global Insomnia Medication Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Insomnia Medication by Application
4.1 Insomnia Medication Market Segment by Application
4.1.1 Adults
4.1.2 Kids
4.2 Global Insomnia Medication Market Size by Application
4.2.1 Global Insomnia Medication Market Size Overview by Application (2018-2029)
4.2.2 Global Insomnia Medication Historic Market Size Review by Application (2018-2023)
4.2.3 Global Insomnia Medication Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Insomnia Medication Sales Breakdown by Application (2018-2023)
4.3.2 Europe Insomnia Medication Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Insomnia Medication Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Insomnia Medication Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Insomnia Medication Sales Breakdown by Application (2018-2023)
5 North America Insomnia Medication by Country
5.1 North America Insomnia Medication Historic Market Size by Country
5.1.1 North America Insomnia Medication Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Insomnia Medication Sales in Volume by Country (2018-2023)
5.1.3 North America Insomnia Medication Sales in Value by Country (2018-2023)
5.2 North America Insomnia Medication Forecasted Market Size by Country
5.2.1 North America Insomnia Medication Sales in Volume by Country (2024-2029)
5.2.2 North America Insomnia Medication Sales in Value by Country (2024-2029)
6 Europe Insomnia Medication by Country
6.1 Europe Insomnia Medication Historic Market Size by Country
6.1.1 Europe Insomnia Medication Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Insomnia Medication Sales in Volume by Country (2018-2023)
6.1.3 Europe Insomnia Medication Sales in Value by Country (2018-2023)
6.2 Europe Insomnia Medication Forecasted Market Size by Country
6.2.1 Europe Insomnia Medication Sales in Volume by Country (2024-2029)
6.2.2 Europe Insomnia Medication Sales in Value by Country (2024-2029)
7 Asia-Pacific Insomnia Medication by Region
7.1 Asia-Pacific Insomnia Medication Historic Market Size by Region
7.1.1 Asia-Pacific Insomnia Medication Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Insomnia Medication Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Insomnia Medication Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Insomnia Medication Forecasted Market Size by Region
7.2.1 Asia-Pacific Insomnia Medication Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Insomnia Medication Sales in Value by Region (2024-2029)
8 Latin America Insomnia Medication by Country
8.1 Latin America Insomnia Medication Historic Market Size by Country
8.1.1 Latin America Insomnia Medication Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Insomnia Medication Sales in Volume by Country (2018-2023)
8.1.3 Latin America Insomnia Medication Sales in Value by Country (2018-2023)
8.2 Latin America Insomnia Medication Forecasted Market Size by Country
8.2.1 Latin America Insomnia Medication Sales in Volume by Country (2024-2029)
8.2.2 Latin America Insomnia Medication Sales in Value by Country (2024-2029)
9 Middle East and Africa Insomnia Medication by Country
9.1 Middle East and Africa Insomnia Medication Historic Market Size by Country
9.1.1 Middle East and Africa Insomnia Medication Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Insomnia Medication Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Insomnia Medication Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Insomnia Medication Forecasted Market Size by Country
9.2.1 Middle East and Africa Insomnia Medication Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Insomnia Medication Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Eisai
10.1.1 Eisai Company Information
10.1.2 Eisai Introduction and Business Overview
10.1.3 Eisai Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Eisai Insomnia Medication Products Offered
10.1.5 Eisai Recent Development
10.2 Merck
10.2.1 Merck Company Information
10.2.2 Merck Introduction and Business Overview
10.2.3 Merck Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Merck Insomnia Medication Products Offered
10.2.5 Merck Recent Development
10.3 Pfizer
10.3.1 Pfizer Company Information
10.3.2 Pfizer Introduction and Business Overview
10.3.3 Pfizer Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Pfizer Insomnia Medication Products Offered
10.3.5 Pfizer Recent Development
10.4 Sanofi
10.4.1 Sanofi Company Information
10.4.2 Sanofi Introduction and Business Overview
10.4.3 Sanofi Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Sanofi Insomnia Medication Products Offered
10.4.5 Sanofi Recent Development
10.5 Takeda
10.5.1 Takeda Company Information
10.5.2 Takeda Introduction and Business Overview
10.5.3 Takeda Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Takeda Insomnia Medication Products Offered
10.5.5 Takeda Recent Development
10.6 Vanda Pharmaceuticals
10.6.1 Vanda Pharmaceuticals Company Information
10.6.2 Vanda Pharmaceuticals Introduction and Business Overview
10.6.3 Vanda Pharmaceuticals Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Vanda Pharmaceuticals Insomnia Medication Products Offered
10.6.5 Vanda Pharmaceuticals Recent Development
10.7 Astellas
10.7.1 Astellas Company Information
10.7.2 Astellas Introduction and Business Overview
10.7.3 Astellas Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Astellas Insomnia Medication Products Offered
10.7.5 Astellas Recent Development
10.8 Dainippon Sumitomo
10.8.1 Dainippon Sumitomo Company Information
10.8.2 Dainippon Sumitomo Introduction and Business Overview
10.8.3 Dainippon Sumitomo Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Dainippon Sumitomo Insomnia Medication Products Offered
10.8.5 Dainippon Sumitomo Recent Development
10.9 ECR Pharmaceuticals (Valeant)
10.9.1 ECR Pharmaceuticals (Valeant) Company Information
10.9.2 ECR Pharmaceuticals (Valeant) Introduction and Business Overview
10.9.3 ECR Pharmaceuticals (Valeant) Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
10.9.4 ECR Pharmaceuticals (Valeant) Insomnia Medication Products Offered
10.9.5 ECR Pharmaceuticals (Valeant) Recent Development
10.10 Flynn Pharma
10.10.1 Flynn Pharma Company Information
10.10.2 Flynn Pharma Introduction and Business Overview
10.10.3 Flynn Pharma Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Flynn Pharma Insomnia Medication Products Offered
10.10.5 Flynn Pharma Recent Development
10.11 Johnson & Johnson
10.11.1 Johnson & Johnson Company Information
10.11.2 Johnson & Johnson Introduction and Business Overview
10.11.3 Johnson & Johnson Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Johnson & Johnson Insomnia Medication Products Offered
10.11.5 Johnson & Johnson Recent Development
10.12 Meda
10.12.1 Meda Company Information
10.12.2 Meda Introduction and Business Overview
10.12.3 Meda Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Meda Insomnia Medication Products Offered
10.12.5 Meda Recent Development
10.13 Somnus Therapeutics
10.13.1 Somnus Therapeutics Company Information
10.13.2 Somnus Therapeutics Introduction and Business Overview
10.13.3 Somnus Therapeutics Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Somnus Therapeutics Insomnia Medication Products Offered
10.13.5 Somnus Therapeutics Recent Development
10.14 Purdue Pharma
10.14.1 Purdue Pharma Company Information
10.14.2 Purdue Pharma Introduction and Business Overview
10.14.3 Purdue Pharma Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Purdue Pharma Insomnia Medication Products Offered
10.14.5 Purdue Pharma Recent Development
10.15 Neurim
10.15.1 Neurim Company Information
10.15.2 Neurim Introduction and Business Overview
10.15.3 Neurim Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Neurim Insomnia Medication Products Offered
10.15.5 Neurim Recent Development
10.16 Minerva Neurosciences
10.16.1 Minerva Neurosciences Company Information
10.16.2 Minerva Neurosciences Introduction and Business Overview
10.16.3 Minerva Neurosciences Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Minerva Neurosciences Insomnia Medication Products Offered
10.16.5 Minerva Neurosciences Recent Development
10.17 Pernix Therapeutics
10.17.1 Pernix Therapeutics Company Information
10.17.2 Pernix Therapeutics Introduction and Business Overview
10.17.3 Pernix Therapeutics Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Pernix Therapeutics Insomnia Medication Products Offered
10.17.5 Pernix Therapeutics Recent Development
10.18 SkyePharma
10.18.1 SkyePharma Company Information
10.18.2 SkyePharma Introduction and Business Overview
10.18.3 SkyePharma Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
10.18.4 SkyePharma Insomnia Medication Products Offered
10.18.5 SkyePharma Recent Development
10.19 Paratek Pharmaceuticals
10.19.1 Paratek Pharmaceuticals Company Information
10.19.2 Paratek Pharmaceuticals Introduction and Business Overview
10.19.3 Paratek Pharmaceuticals Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
10.19.4 Paratek Pharmaceuticals Insomnia Medication Products Offered
10.19.5 Paratek Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Insomnia Medication Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Insomnia Medication Industrial Chain Analysis
11.4 Insomnia Medication Market Dynamics
11.4.1 Insomnia Medication Industry Trends
11.4.2 Insomnia Medication Market Drivers
11.4.3 Insomnia Medication Market Challenges
11.4.4 Insomnia Medication Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Insomnia Medication Distributors
12.3 Insomnia Medication Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock